Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2025-01-07 00:00:00 ET · period of report 2025-01-03 · accession 0000950170-25-003012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-07 | 2025-01-03 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale | $12.18 | -26.8K | 941.1K | -3% | -$326.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-03 | S | D | 26,807 | $12.18 | 941,115 | D | — | — |